Zobrazeno 1 - 10
of 73
pro vyhledávání: '"Alan B. Sachs"'
Autor:
Marija Tadin-Strapps, Laurence B. Peterson, Anne-Marie Cumiskey, Raymond L. Rosa, Vivienne Halili Mendoza, Jose Castro-Perez, Oscar Puig, Liwen Zhang, Walter R. Strapps, Satyasri Yendluri, Lori Andrews, Victoria Pickering, Julie Rice, Lily Luo, Zhu Chen, Samnang Tep, Brandon Ason, Elizabeth Polizzi Somers, Alan B. Sachs, Steven R. Bartz, Jenny Tian, Jayne Chin, Brian K. Hubbard, Kenny K. Wong, Lyndon J. Mitnaul
Publikováno v:
Journal of Lipid Research, Vol 52, Iss 6, Pp 1084-1097 (2011)
Increased serum apolipoprotein (apo)B and associated LDL levels are well-correlated with an increased risk of coronary disease. ApoE–/– and low density lipoprotein receptor (LDLr)–/– mice have been extensively used for studies of coronary ath
Externí odkaz:
https://doaj.org/article/0b029968df064a1196d6bf73ea9f6a26
Autor:
Brandon Ason, Samnang Tep, Jr. Harry R. Davis, Yiming Xu, Glen Tetzloff, Beverly Galinski, Ferdie Soriano, Natalya Dubinina, Lei Zhu, Alice Stefanni, Kenny K. Wong, Marija Tadin-Strapps, Steven R. Bartz, Brian Hubbard, Mollie Ranalletta, Alan B. Sachs, W. Michael Flanagan, Alison Strack, Nelly A. Kuklin
Publikováno v:
Journal of Lipid Research, Vol 52, Iss 4, Pp 679-687 (2011)
Reducing circulating LDL-cholesterol (LDL-c) reduces the risk of cardiovascular disease in people with hypercholesterolemia. Current approaches to reduce circulating LDL-c include statins, which inhibit cholesterol synthesis, and ezetimibe, which blo
Externí odkaz:
https://doaj.org/article/5914edaf91c54338b6cfc9ad1842ba30
Autor:
Ronald C Hendrickson, Anita Y H Lee, Qinghua Song, Andy Liaw, Matt Wiener, Cloud P Paweletz, Jeffrey L Seeburger, Jenny Li, Fanyu Meng, Ekaterina G Deyanova, Matthew T Mazur, Robert E Settlage, Xuemei Zhao, Katie Southwick, Yi Du, Dan Holder, Jeffrey R Sachs, Omar F Laterza, Aimee Dallob, Derek L Chappell, Karen Snyder, Vijay Modur, Elizabeth King, Catharine Joachim, Andrey Y Bondarenko, Mark Shearman, Keith A Soper, A David Smith, William Z Potter, Ken S Koblan, Alan B Sachs, Nathan A Yates
Publikováno v:
PLoS ONE, Vol 10, Iss 8, p e0135365 (2015)
Disease modifying treatments for Alzheimer's disease (AD) constitute a major goal in medicine. Current trends suggest that biomarkers reflective of AD neuropathology and modifiable by treatment would provide supportive evidence for disease modificati
Externí odkaz:
https://doaj.org/article/9acb46913f794a2a8b1b2a7a679cc6a4
Autor:
W. Michael Flanagan, Samnang Tep, Brian K. Hubbard, Alice C. Stefanni, Thomas P. Roddy, Alan B. Sachs, Thomas Hankemeier, Brandon Ason, Nelly A. Kuklin, Jose Castro-Perez, Lyndon J. Mitnaul, Marija Tadin-Strapps
Publikováno v:
Lipids
The association between hypercholesterolemia and elevated serum apolipoprotein B (APOB) has generated interest in APOB as a therapeutic target for patients at risk of developing cardiovascular disease. In the clinic, mipomersen, an antisense oligonuc
Autor:
Stephanie Young, Weikang Tao, Bonnie J. Howell, Ed Carlini, Marc Abrams, Edward Keough, Alan B. Sachs, Laura Sepp-Lorenzino, Andrea Matter, Karen R. Leander, Bin Shi
Publikováno v:
Journal of Histochemistry & Cytochemistry. 59:727-740
Chemically stabilized small interfering RNA (siRNA) can be delivered systemically by intravenous injection of lipid nanoparticles (LNPs) in rodents and primates. The biodistribution and kinetics of LNP–siRNA delivery in mice at organ and cellular r
Autor:
Kenny K. Wong, Brian K. Hubbard, Alison M. Strack, Beverly Galinski, Mollie Ranalletta, Lei Zhu, Harry R. Davis, Alice C. Stefanni, Natalya Dubinina, Glen Tetzloff, Samnang Tep, Ferdie Soriano, Yiming Xu, Marija Tadin-Strapps, Brandon Ason, Nelly A. Kuklin, Alan B. Sachs, Steven R. Bartz, W. Michael Flanagan
Publikováno v:
Journal of Lipid Research, Vol 52, Iss 4, Pp 679-687 (2011)
Reducing circulating LDL-cholesterol (LDL-c) reduces the risk of cardiovascular disease in people with hypercholesterolemia. Current approaches to reduce circulating LDL-c include statins, which inhibit cholesterol synthesis, and ezetimibe, which blo
Autor:
Marc Abrams, Jessica Seitzer, Laura Sepp-Lorenzino, Yi Pei, René Bartz, Paul A. Burke, Nathalie Innocent, Yan Xu, Stanley F. Barnett, Craig Cherrin, Colin J. Pomerantz, Paula J. Hancock, Hangchun Zhang, Martin Koser, Alan B. Sachs, Nelly A. Kuklin
Publikováno v:
RNA. 16:2553-2563
Effective small interfering RNA (siRNA)–mediated therapeutics require the siRNA to be delivered into the cellular RNA-induced silencing complex (RISC). Quantitative information of this essential delivery step is currently inferred from the efficacy
Autor:
Alan B. Sachs, Walter Strapps, Barry A. Polisky, Gladys T. Muiru, Stacey Orsborn, Victoria Pickering, Julie Rice, Steven R. Bartz
Publikováno v:
Nucleic Acids Research
The use of short interfering RNAs (siRNA) in animals for target validation or as potential therapeutics is hindered by the short physical half-life when delivered as unencapsulated material and in turn the short active half-life of siRNAs in vivo. He
Autor:
Alan B. Sachs, Matthew C. Wiener, Ernst S. Henle, Adam J. Simon, Andy Liaw, Andrey Bondarenko, Nathan A. Yates, Fanyu Meng, Ronald C. Hendrickson, Jacquelynn J. Cook, Anita Y. H. Lee, Holly Funk Sleph, Mark S. Shearman, Sethu Sankaranarayanan, Robert E. Settlage, Jeffrey R. Sachs, Marie A. Holahan, Brandon T. Hunt, Cloud P. Paweletz, Qinghua Song
Publikováno v:
Journal of Proteome Research. 9:1392-1401
The rapid identification of protein biomarkers in biofluids is important to drug discovery and development. Here, we describe a general proteomic approach for the discovery and identification of proteins that exhibit a statistically significant diffe
Autor:
Joseph P. Davide, Xianzhi Mao, Martha A. DiPietro, Jessica Seitzer, Weimin Wang, Marc Abrams, Laura Sepp-Lorenzino, Steven M. Stirdivant, Martin Koser, Paul A. Burke, Stephanie Williams, Vasant Jadhav, Andrew W. Shaw, Alan B. Sachs
Publikováno v:
Molecular Therapy. 18:171-180
Despite recent progress, systemic delivery remains the major hurdle for development of safe and effective small inhibitory RNA (siRNA)–based therapeutics. Encapsulation of siRNA into liposomes is a promising option to overcome obstacles such as low